SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10362	Companies
215726	Keywords
145492	Articles
114253	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 02/17/2026 at 12:00, 2 months 17 days ago

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus Shows Extended Benefits for Infants Against RSV

Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus prouve son efficacité au-delà de la première saison du VRS

Sanofi VRS Beyfortus Nourrissons Immunisation
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus proves its effectiveness beyond the first season of VRS

Sanofi VRS Beyfortus Infants Immunization
BRIEF

published on 02/16/2026 at 07:05, 2 months 19 days ago

Beyfortus présente des bénéfices prolongés chez les nourrissons contre le VRS

Beyfortus Réduction Des Hospitalisations Santé Infantile Vaccination Contre Le VRS Étude NIRSE-GAL
PRESS RELEASE

published on 02/16/2026 at 07:00, 2 months 19 days ago

Communiqué de presse : L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS
Étude sur Beyfortus montrant réduction significative des hospitalisations liées au VRS chez les nourrissons. Résultats présentés dans The Lancet Infectious Diseases et à la conférence 2026 de la Semaine du vaccin contre le VRS

VRS Étude Beyfortus Nourrissons Hospitalisations
PRESS RELEASE

published on 02/16/2026 at 07:00, 2 months 19 days ago

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings

RSV Beyfortus Infants Immunization Hospitalizations
BRIEF

published on 02/10/2026 at 15:05, 2 months 24 days ago

Sanofi finalise l'acquisition de Dynavax

Acquisition Biopharma Sanofi Vaccins Dynavax
BRIEF

published on 02/10/2026 at 15:05, 2 months 24 days ago

Sanofi Finalizes Acquisition of Dynavax

Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE

published on 02/10/2026 at 15:00, 2 months 24 days ago

Press Release: Sanofi completes the acquisition of Dynavax
Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities

Acquisition Sanofi Vaccine Immunization Dynavax

Accesswire

Published on 05/07/2026 at 09:05, 2 hours ago

Nano One Appoints Jason Zandberg as Director of Capital Markets
Published on 05/07/2026 at 05:40, 5 hours 25 minutes ago

New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 9 hours 5 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 11 hours 35 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 12 hours ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 10:45, 20 minutes ago

REPLOID secures growth financing in the double-digit million-euro range from Raiffeisen Bank International
Published on 05/07/2026 at 10:35, 29 minutes ago

Encouraging New Data: Grafalon Benefits High-Risk Pediatric HSCT Patients in the FORUM Study
Published on 05/07/2026 at 10:35, 30 minutes ago

TRATON GROUP issues its first Green Bond and Green Loan for a total of €850 million for investments in battery-electric commercial vehicles under its Group-wide Green Finance Framework
Published on 05/07/2026 at 10:26, 39 minutes ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 05/07/2026 at 10:00, 1 hour 5 minutes ago

Mirah Investment & Development Announces Strategic Partnership with RV Capital Across Portfolio of Hospitality Brands

Les Echos

Published on 05/07/2026 at 07:43, 3 hours 22 minutes ago

ENGIE - Q1 2026 financial information
Published on 05/07/2026 at 07:43, 3 hours 22 minutes ago

ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 17 hours 5 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 17 hours 5 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 17 hours 5 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026

View all LES ECHOS COMFI WIRE